Wilmar International Ltd (RTHA.HA)
Hanover - Hanover Delayed Price. Currency in EUR
Add to watchlist
As of 08:45AM CEST. Market open.
| Previous Close | 2.1000 |
| Open | 2.0920 |
| Bid | 2.1020 x N/A |
| Ask | 2.1650 x N/A |
| Day's Range | 2.0920 - 2.0920 |
| 52 Week Range | 2.0850 - 2.6020 |
| Volume | |
| Avg. Volume | 8 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.